Exponent (NASDAQ:EXPO) Releases Earnings Results, Beats Expectations By $0.04 EPS

Exponent (NASDAQ:EXPO) posted its quarterly earnings data on Thursday. The business services provider reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.60 by $0.04, FiscalAI reports. The firm had revenue of $173.73 million for the quarter, compared to the consensus estimate of $149.64 million. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The company’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.55 earnings per share.

Here are the key takeaways from Exponent’s conference call:

• Strong third-quarter performance: Net revenue rose 12% to $153.1 million, EBITDA increased 16% with margin expanding to 29.4%, and utilization reached 76.7%. The company cited broad-based demand across user research, disputes, failure analysis, and product safety.
• Exponent raised its full-year 2026 outlook to 10%-11% net revenue growth and 28%-28.3% EBITDA margin, up from 27.6% in 2025. Management expects strong business activity to continue despite seasonally lower fourth-quarter utilization.
• AI-related work now represents an estimated 15%-20% of the business, spanning data-center infrastructure, advanced transportation systems, user research, product safety, and explainability of AI-driven decisions. Management said inquiries are increasing as AI moves into physical products and real-world applications.
• The engineering and scientific segment grew 13%, while environmental and health revenue increased only 3%. Management is investing in senior talent and emerging-chemical capabilities, including PFAS-related work, to support a future reacceleration.
• Exponent returned capital through $171 million of stock repurchases over the past 12 months, reducing diluted shares outstanding by 5%, and paid $14.7 million in dividends during the quarter. No shares were repurchased in the third quarter, but $50 million remains authorized for future buybacks.

Exponent Stock Up 1.6%

Exponent stock opened at $78.31 on Friday. Exponent has a 52 week low of $51.91 and a 52 week high of $81.95. The company has a market capitalization of $3.72 billion, a price-to-earnings ratio of 35.12 and a beta of 0.69. The stock has a 50-day moving average price of $69.97 and a 200 day moving average price of $66.61.

Exponent Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 18th. Stockholders of record on Friday, December 4th will be paid a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Friday, December 4th. Exponent’s dividend payout ratio (DPR) is presently 55.61%.

Key Headlines Impacting Exponent

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Q3 earnings and revenue beat estimates: Exponent reported adjusted earnings of $0.64 per share versus the $0.60 consensus estimate. Revenue reached $173.7 million, substantially above analysts’ $149.6 million forecast, and increased from the prior-year period. Exponent earnings report
• Positive Sentiment: Profitability and cash generation remained solid: Net income was approximately $30.9 million, operating profit rose 44.2% to $41.9 million, and operating cash flow totaled $30.9 million. The results suggest operating leverage as revenue expanded. Exponent Q3 financial results
• Positive Sentiment: 2026 outlook raised: Management reportedly increased its full-year outlook following the strong quarter, improving expectations for future earnings and supporting the investment case. Exponent raises 2026 outlook
• Positive Sentiment: Quarterly dividend maintained: The board declared a $0.31-per-share dividend payable December 18 to shareholders of record December 4. The annualized payout is $1.24 per share, representing a yield of about 1.6%. Exponent dividend announcement
• Neutral Sentiment: Potential acquisition: Exponent was reported to be acquiring Crane Building Services & Utilities in a carve-out transaction. Financial terms and the expected earnings impact were not provided, leaving the near-term effect uncertain. Exponent acquisition report
• Negative Sentiment: Insider selling and valuation are risks: Reported insider activity over the past six months included substantially more sales than purchases. In addition, EXPO’s price-to-earnings ratio is about 35, leaving the stock vulnerable to profit-taking if growth or guidance disappoints.

Wall Street Analyst Weigh In

EXPO has been the topic of several research analyst reports. Weiss Ratings raised shares of Exponent from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, October 9th. JPMorgan Chase & Co. upped their price target on shares of Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Finally, UBS Group set a $72.00 price target on shares of Exponent and gave the stock a “neutral” rating in a report on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $81.00.

Insiders Place Their Bets

In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $66.28, for a total transaction of $113,139.96. Following the completion of the transaction, the chief executive officer directly owned 129,108 shares of the company’s stock, valued at approximately $8,557,278.24. This trade represents a 1.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.70% of the company’s stock.

Exponent Company Profile

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.